CCXI - ChemoCentryx Inc. (CCXI) CEO Thomas Schall on Q4 2021 Results - Earnings Call Transcript

ChemoCentryx, Inc. (CCXI) Q4 2021 Earnings Conference Call March 1, 2022 05:00 p.m. ET Company Representatives Dr. Thomas Schall - Chairman, President and Chief Executive Officer Susan Kanaya - Executive Vice President, Chief Financial and Administrative Officer Tausif Butt - Executive Vice President, Chief Operating Officer Bill Slattery, Jr. - Vice President of Investor Relations & Corporate Communications Conference Call Participants Ryan Deschner -Raymond James Dae Gon Ha - Stifel Michelle Gilson - Canaccord Genuity Yanan Zhu - Wells Fargo Securities Ed White - H.C. Wainwright Edward Tenthoff - Piper Sandler Anupam Rama - JPMorgan Presentation Operator Good afternoon, and welcome to the ChemoCentryx's Fourth Quarter and Full Year 2021 Financial Results Conference Call. At this time all participants are in a listen-only mode. [Operator Instructions]. As a reminder, this conference call will be recorded. And I would now like to turn the call over to Bill Slattery, Jr., Vice

For further details see:

ChemoCentryx, Inc. (CCXI) CEO Thomas Schall on Q4 2021 Results - Earnings Call Transcript